Corrigendum to "Molsidomine alleviates acetic acid-induced colitis in rats by reducing oxidative stress, inflammation and apoptosis" [Int. Immunopharmacol. 99 (2021) 108005]
- PMID: 35115257
- DOI: 10.1016/j.intimp.2022.108575
Corrigendum to "Molsidomine alleviates acetic acid-induced colitis in rats by reducing oxidative stress, inflammation and apoptosis" [Int. Immunopharmacol. 99 (2021) 108005]
Retraction in
-
Retraction notice to "Corrigendum to "Molsidomine alleviates acetic acid-induced colitis in rats by reducing oxidative stress, inflammation and apoptosis" [Int. Immunopharmacol. 105 (2022) 108575].Int Immunopharmacol. 2025 Feb 20;148:114169. doi: 10.1016/j.intimp.2025.114169. Epub 2025 Feb 4. Int Immunopharmacol. 2025. PMID: 39904683 No abstract available.
Erratum for
-
Molsidomine alleviates acetic acid-induced colitis in rats by reducing oxidative stress, inflammation and apoptosis.Int Immunopharmacol. 2021 Oct;99:108005. doi: 10.1016/j.intimp.2021.108005. Epub 2021 Jul 27. Int Immunopharmacol. 2021. Retraction in: Int Immunopharmacol. 2025 Feb 20;148:114171. doi: 10.1016/j.intimp.2025.114171. PMID: 34330056 Retracted.
Publication types
LinkOut - more resources
Full Text Sources
